Health state utility values and quality of life in patients receiving ripretinib in the phase 3 INVICTUS trial and a real-world evidence study in China Meeting Abstract
| Authors: | Jones, R. L.; Blay, J. Y.; Chi, P.; Bauer, S.; Gelderblom, H.; Shen, L.; He, Y. L.; Heinrich, M. C.; Schöffski, P.; Zalcberg, J. R.; Harrow, B.; Sherman, M. L.; Ruiz-Soto, R.; Becker, C.; von Mehren, M. |
| Abstract Title: | Health state utility values and quality of life in patients receiving ripretinib in the phase 3 INVICTUS trial and a real-world evidence study in China |
| Meeting Title: | ISPOR Europe 2022 |
| Journal Title: | Value in Health |
| Volume: | 25 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2022 Nov 6-9 |
| Meeting Location: | Vienna, Italy |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2022-12-01 |
| Start Page: | S14 |
| End Page: | S15 |
| Language: | English |
| ACCESSION: | WOS:000897594900062 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2022.09.073 |
| Notes: | Meeting Abstract: P61 -- Source: Wos |
